BamSEC and AlphaSense Join Forces
Learn More

Spero Therapeutics Inc. – Indentures

NASDAQ: SPRO    
Share price (8/17/26): $1.19    
Market cap (8/17/26): $69.3 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.11
from S-3 50 pages Spero Therapeutics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.10
from S-3 51 pages Spero Therapeutics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.5
from S-8 17 pages Spero Therapeutics, Inc. 2019 Inducement Equity Incentive Plan
12/34/56
EX-4.7
from S-8 6 pages Spero Therapeutics, Inc. Restricted Stock Unit Award Grant Notice Restricted Stock Unit Award Grant Under the Company’s 2019 Inducement Equity Incentive Plan
12/34/56
EX-4.6
from S-8 8 pages Spero Therapeutics, Inc. Stock Option Agreement—incorporated Terms and Conditions
12/34/56
EX-4.5
from S-8 17 pages Spero Therapeutics, Inc. 2019 Inducement Equity Incentive Plan
12/34/56
EX-4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.6
from S-8 11 pages Spero Therapeutics, Inc. Stock Option Agreement—incorporated Terms and Conditions
12/34/56
EX-4.10
from S-3 51 pages Spero Therapeutics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.9
from S-3 51 pages Spero Therapeutics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.3
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.8
from S-3 42 pages Spero Therapeutics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.7
from S-3 42 pages Spero Therapeutics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.2
from S-1 49 pages Spero Therapeutics, Inc. Investors’ Rights Agreement June 30, 2017
12/34/56
EX-4.1
from S-1 2 pages Indenture or similar
12/34/56
EX-4
from DRS 49 pages Spero Therapeutics, Inc. Investors’ Rights Agreement June 30, 2017
12/34/56